Literature DB >> 8323334

Dual marker one day pancreolauryl test.

M R Green1, S Austin, L T Weaver.   

Abstract

There is a pressing need for a simple non-invasive test of exocrine pancreatic function for use in children. The pancreolauryl test has been modified by the addition of a second marker (mannitol) to achieve a single day test without the need for two timed urine collections. Six healthy subjects and nine patients with cystic fibrosis were studied. Fluorescein, fluorescein dilaurate, and mannitol were taken by mouth, alone or in combinations, followed by 10 hour urine collections in two hourly aliquots to study the comparative pharmacokinetics of these markers. Urinary fluorescein was determined spectrophotometrically and urinary mannitol enzymatically. When fluorescein dilaurate and mannitol were taken together and the results expressed as ratios of percentage fluorescein to percentage mannitol recovery (F:M ratio) (mean (SD)) there was clear discrimination between healthy subjects and those with cystic fibrosis regardless of enzyme replacement treatment (57.3 (18.2) v 3.4 (1.4) v 3.2 (1.6) respectively). The differences in F:M ratios reached statistical significance in urinary aliquots collected between two and eight hours after marker ingestion. This single day tubeless test will greatly simplify the investigation of the child with suspected exocrine pancreatic dysfunction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8323334      PMCID: PMC1029334          DOI: 10.1136/adc.68.5.649

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  24 in total

1.  Inulin and mannitol distribution volumes in canine small intestinal tissues in vivo.

Authors:  E Grim; A Simonds; C Oeljen; J Cheng
Journal:  Am J Physiol       Date:  1973-01

2.  Mannitol absorption and metabolism in man.

Authors:  S M Nasrallah; F L Iber
Journal:  Am J Med Sci       Date:  1969-08       Impact factor: 2.378

3.  Fluorescein dilaurate test of exocrine pancreatic function in cystic fibrosis.

Authors:  A M Dalzell; D P Heaf
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

4.  Fluorescein dilaurate--tubeless test for pancreatic exocrine failure.

Authors:  R E Barry; R Barry; M D Ene; G Parker
Journal:  Lancet       Date:  1982-10-02       Impact factor: 79.321

5.  [Diagnosis of pancreatic insufficiency using fluorescein-dilaurate in children (author's transl)].

Authors:  P Neis; F Zeuss
Journal:  Monatsschr Kinderheilkd       Date:  1981-06       Impact factor: 0.323

6.  Lipolytic enzymes of the human pancreas. I. A highly sensitive, specific, and simple measurement of cholesterol ester hydrolase activity.

Authors:  J G Meyer-Bertenrath
Journal:  Enzyme       Date:  1982

7.  Conservation of mannitol, lactulose, and raffinose by the human colon.

Authors:  D R Saunders; H S Wiggins
Journal:  Am J Physiol       Date:  1981-11

8.  [Diagnosis of pancreatic insufficiency with fluorescein dilaurate in patients with cystic fibrosis (author's transl)].

Authors:  W Schönberger; D Weitzel
Journal:  Monatsschr Kinderheilkd       Date:  1980-04

9.  [Oral pancreas function test with FDL in the diagnosis of chronic pancreatitis].

Authors:  P Malfertheiner; M Peter; U Junge; H Ditschuneit
Journal:  Klin Wochenschr       Date:  1983-02-15

10.  Evaluation of mannitol for use as a probe marker of gastrointestinal permeability in man.

Authors:  M F Laker; H J Bull; I S Menzies
Journal:  Eur J Clin Invest       Date:  1982-12       Impact factor: 4.686

View more
  3 in total

Review 1.  Control of malabsorption in cystic fibrosis.

Authors:  J M Littlewood; S P Wolfe
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

2.  Spot urine pancreolauryl test for use in infancy.

Authors:  M R Green; S Austin; P McClean; S Jolliffe; L T Weaver
Journal:  Arch Dis Child       Date:  1995-03       Impact factor: 3.791

3.  Dual marker one day pancreolauryl test.

Authors:  J W Puntis
Journal:  Arch Dis Child       Date:  1993-10       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.